Diversified Bio-Medics, Inc.

[HOME PAGE]  [ABOUT US]   [PROJECT]  [PEOPLE]  [INVESTORS]  [CONTACT US]  [LINKS] [NEWS RELEASES]

THE PROJECT

The focus of this facility will be agility, flexibility and capital efficiency.

Single use (disposable) technology will be applied to this facility as allowed by Health Canada/FDA.

Strategic collaborations are an important part of the Company’s business model and strategy.

This will allow DBMI to use innovative biomanufacturing platforms. 

The requirements of the design of the biomanufacturing facility is to:

• Minimize capital cost with lower capital expenditures
• Handle a wide range of processes
• Be flexible and quickly reconfigurable
• Assure a high level of product quality
• Lower risk of contamination through decreased operator intervention
• Minimize labor, time and operating cost
• Reduced cleaning and validation requirements
• Reduce regulatory risk by eliminating certain validation requirements
• Increased flexibility in a multi-product facility
• Greater process efficiency and productivity
• Accelerate time to commercialization

Diversified Bio-Medics, Inc. is committed to providing premium manufacturing facilities, tailored systems, and expert support to biotechnology companies.

DBMI’s validated current Good Manufacturing Practice (cGMP) facilities help biotechnology and biopharmaceutical companies expedite their development of candidate biopharmaceuticals. 

DBMI will be distinguished from other providers by providing complete biomanufacturing operations for short, medium or long-term production needs and by the company’s service and craftsmanship.

 

 

 

All Information & Related Materials are copyright ©2005 Diversified Bio-Medics, Inc.

1.6  Conduct a corporate social responsibility study